In GC, DNMT3A is enriched in tumor tissues, and it is recognized as an independent poor prognostic factor12, 13; thus, it is important to assess its biological function and the molecular mechanism underlying its promotion of GC individually. Here, DNMT3A is linked to gastric cancer.